Wikidata

(Q65381372)

English

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
An International Multi-centre Open-label 2-arm Phase III Trial of Adjuvant Bevacizumab in "Triple Negative" Breast Cancer. (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Bosnia and Herzegovina
0 references
Brazil
0 references
Canada
0 references
Costa Rica
0 references
Czech Republic
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Israel
0 references
Italy
0 references
Japan
0 references
Malaysia
0 references
Mexico
0 references
Netherlands
0 references
New Zealand
0 references
Peru
0 references
Philippines
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Singapore
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Taiwan
0 references
Thailand
0 references
United Kingdom
0 references
start time
December 2007
0 references
end time
February 2012
0 references
number of participants
2,591
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65381372&oldid=2237492262"